Lipid mediators contribute to oxygen-radical-induced airway responses in sheep

M. W. Lansing, E. Mansour, A. Ahmed, A. Cortes, L. Garcia, I. T. Lauredo, Adam Wanner, W. M. Abraham

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The purpose of this study was to determine if the bronchoconstriction and airway hyperresponsiveness (AHR) resulting from aerosolized xanthine (x; 0.1%)-xanthine oxidase (xo; 4.1 U) and the subsequent production of oxygen radicals is mediated by the secondary generation of lipid mediators. In seven conscious sheep, specific lung resistance (SRL) was measured before and after x-xo challenge; ~30 min later when SRL had returned to baseline, airway responsiveness to carbachol was determined from dose-response curves by calculating the cumulative provocating dose of carbachol in breath units (BU, defined as one breath of a 1% wt/vol carbachol solution) that increased SRL 400% over baseline (PD400). Inhaled x-xo caused in immediate increase in SRL of 162 ± 36% (mean ± SE; p < 0.05) over baseline and decreased PD400 from a baseline value of 32.5 ± 5.0 to 16.6 ± 1.7 BU (p < 0.05). Pretreatment with the H2O2 scavenger, catalase (CAT,; 38 mg aerosol), methylprednisolone succinate (MS; 1 mg/kg given intravenously), the cyclooxygenase inhibitor, indomethacin (IND; 2 mg/kg given intravenously), and the PAF antagonist, WEB-2086 (3 mg/kg given intravenously) all attenuated the x-xo-induced increase in SRL (p < 0.05); the leukotriene D4 antagonist, MK-571 (5 mg by aerosol) had no effect. All agents inhibited the x-xo-induced decrease in PD400: mean BUs were 27 after CAT, 32 after WEB-2086, 34 after IND, 31 after MS, and 25 after MK-571 (all p < 0.05 versus x-xo alone). In a cell-free system in vitro, x-xo produced 774 ± 41 ng OH·/ml (n = 9) and CAT (50 μg/ml) inhibited this reaction by 74 ± 11% (n = 7, p < 0.05); all other drugs were ineffective, indicating that they did not have nonspecific radical scavenging action. In subsequent experiments, CAT pretreatment had no effect on PAF-induced bronchoconstriction or AHR, suggesting that radical-induced generation of lipid mediators occurred first. These results suggest that in sheep, the secondary generation of arachidonic acid metabolites contributes to x-xo-induced bronchoconstriction and AHR.

Original languageEnglish
Pages (from-to)1291-1296
Number of pages6
JournalAmerican Review of Respiratory Disease
Volume144
Issue number6
StatePublished - Dec 1 1991

Fingerprint

WEB 2086
verlukast
Bronchoconstriction
Carbachol
Reactive Oxygen Species
Sheep
Aerosols
Lipids
Methylprednisolone Hemisuccinate
Leukotriene D4
Leukotriene Antagonists
Xanthine
Cyclooxygenase Inhibitors
Cell-Free System
Xanthine Oxidase
Arachidonic Acid
Indomethacin
Catalase
Lung
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Lansing, M. W., Mansour, E., Ahmed, A., Cortes, A., Garcia, L., Lauredo, I. T., ... Abraham, W. M. (1991). Lipid mediators contribute to oxygen-radical-induced airway responses in sheep. American Review of Respiratory Disease, 144(6), 1291-1296.

Lipid mediators contribute to oxygen-radical-induced airway responses in sheep. / Lansing, M. W.; Mansour, E.; Ahmed, A.; Cortes, A.; Garcia, L.; Lauredo, I. T.; Wanner, Adam; Abraham, W. M.

In: American Review of Respiratory Disease, Vol. 144, No. 6, 01.12.1991, p. 1291-1296.

Research output: Contribution to journalArticle

Lansing, MW, Mansour, E, Ahmed, A, Cortes, A, Garcia, L, Lauredo, IT, Wanner, A & Abraham, WM 1991, 'Lipid mediators contribute to oxygen-radical-induced airway responses in sheep', American Review of Respiratory Disease, vol. 144, no. 6, pp. 1291-1296.
Lansing MW, Mansour E, Ahmed A, Cortes A, Garcia L, Lauredo IT et al. Lipid mediators contribute to oxygen-radical-induced airway responses in sheep. American Review of Respiratory Disease. 1991 Dec 1;144(6):1291-1296.
Lansing, M. W. ; Mansour, E. ; Ahmed, A. ; Cortes, A. ; Garcia, L. ; Lauredo, I. T. ; Wanner, Adam ; Abraham, W. M. / Lipid mediators contribute to oxygen-radical-induced airway responses in sheep. In: American Review of Respiratory Disease. 1991 ; Vol. 144, No. 6. pp. 1291-1296.
@article{920936b9f3e6471c95f390ee8b52f59b,
title = "Lipid mediators contribute to oxygen-radical-induced airway responses in sheep",
abstract = "The purpose of this study was to determine if the bronchoconstriction and airway hyperresponsiveness (AHR) resulting from aerosolized xanthine (x; 0.1{\%})-xanthine oxidase (xo; 4.1 U) and the subsequent production of oxygen radicals is mediated by the secondary generation of lipid mediators. In seven conscious sheep, specific lung resistance (SRL) was measured before and after x-xo challenge; ~30 min later when SRL had returned to baseline, airway responsiveness to carbachol was determined from dose-response curves by calculating the cumulative provocating dose of carbachol in breath units (BU, defined as one breath of a 1{\%} wt/vol carbachol solution) that increased SRL 400{\%} over baseline (PD400). Inhaled x-xo caused in immediate increase in SRL of 162 ± 36{\%} (mean ± SE; p < 0.05) over baseline and decreased PD400 from a baseline value of 32.5 ± 5.0 to 16.6 ± 1.7 BU (p < 0.05). Pretreatment with the H2O2 scavenger, catalase (CAT,; 38 mg aerosol), methylprednisolone succinate (MS; 1 mg/kg given intravenously), the cyclooxygenase inhibitor, indomethacin (IND; 2 mg/kg given intravenously), and the PAF antagonist, WEB-2086 (3 mg/kg given intravenously) all attenuated the x-xo-induced increase in SRL (p < 0.05); the leukotriene D4 antagonist, MK-571 (5 mg by aerosol) had no effect. All agents inhibited the x-xo-induced decrease in PD400: mean BUs were 27 after CAT, 32 after WEB-2086, 34 after IND, 31 after MS, and 25 after MK-571 (all p < 0.05 versus x-xo alone). In a cell-free system in vitro, x-xo produced 774 ± 41 ng OH·/ml (n = 9) and CAT (50 μg/ml) inhibited this reaction by 74 ± 11{\%} (n = 7, p < 0.05); all other drugs were ineffective, indicating that they did not have nonspecific radical scavenging action. In subsequent experiments, CAT pretreatment had no effect on PAF-induced bronchoconstriction or AHR, suggesting that radical-induced generation of lipid mediators occurred first. These results suggest that in sheep, the secondary generation of arachidonic acid metabolites contributes to x-xo-induced bronchoconstriction and AHR.",
author = "Lansing, {M. W.} and E. Mansour and A. Ahmed and A. Cortes and L. Garcia and Lauredo, {I. T.} and Adam Wanner and Abraham, {W. M.}",
year = "1991",
month = "12",
day = "1",
language = "English",
volume = "144",
pages = "1291--1296",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Lipid mediators contribute to oxygen-radical-induced airway responses in sheep

AU - Lansing, M. W.

AU - Mansour, E.

AU - Ahmed, A.

AU - Cortes, A.

AU - Garcia, L.

AU - Lauredo, I. T.

AU - Wanner, Adam

AU - Abraham, W. M.

PY - 1991/12/1

Y1 - 1991/12/1

N2 - The purpose of this study was to determine if the bronchoconstriction and airway hyperresponsiveness (AHR) resulting from aerosolized xanthine (x; 0.1%)-xanthine oxidase (xo; 4.1 U) and the subsequent production of oxygen radicals is mediated by the secondary generation of lipid mediators. In seven conscious sheep, specific lung resistance (SRL) was measured before and after x-xo challenge; ~30 min later when SRL had returned to baseline, airway responsiveness to carbachol was determined from dose-response curves by calculating the cumulative provocating dose of carbachol in breath units (BU, defined as one breath of a 1% wt/vol carbachol solution) that increased SRL 400% over baseline (PD400). Inhaled x-xo caused in immediate increase in SRL of 162 ± 36% (mean ± SE; p < 0.05) over baseline and decreased PD400 from a baseline value of 32.5 ± 5.0 to 16.6 ± 1.7 BU (p < 0.05). Pretreatment with the H2O2 scavenger, catalase (CAT,; 38 mg aerosol), methylprednisolone succinate (MS; 1 mg/kg given intravenously), the cyclooxygenase inhibitor, indomethacin (IND; 2 mg/kg given intravenously), and the PAF antagonist, WEB-2086 (3 mg/kg given intravenously) all attenuated the x-xo-induced increase in SRL (p < 0.05); the leukotriene D4 antagonist, MK-571 (5 mg by aerosol) had no effect. All agents inhibited the x-xo-induced decrease in PD400: mean BUs were 27 after CAT, 32 after WEB-2086, 34 after IND, 31 after MS, and 25 after MK-571 (all p < 0.05 versus x-xo alone). In a cell-free system in vitro, x-xo produced 774 ± 41 ng OH·/ml (n = 9) and CAT (50 μg/ml) inhibited this reaction by 74 ± 11% (n = 7, p < 0.05); all other drugs were ineffective, indicating that they did not have nonspecific radical scavenging action. In subsequent experiments, CAT pretreatment had no effect on PAF-induced bronchoconstriction or AHR, suggesting that radical-induced generation of lipid mediators occurred first. These results suggest that in sheep, the secondary generation of arachidonic acid metabolites contributes to x-xo-induced bronchoconstriction and AHR.

AB - The purpose of this study was to determine if the bronchoconstriction and airway hyperresponsiveness (AHR) resulting from aerosolized xanthine (x; 0.1%)-xanthine oxidase (xo; 4.1 U) and the subsequent production of oxygen radicals is mediated by the secondary generation of lipid mediators. In seven conscious sheep, specific lung resistance (SRL) was measured before and after x-xo challenge; ~30 min later when SRL had returned to baseline, airway responsiveness to carbachol was determined from dose-response curves by calculating the cumulative provocating dose of carbachol in breath units (BU, defined as one breath of a 1% wt/vol carbachol solution) that increased SRL 400% over baseline (PD400). Inhaled x-xo caused in immediate increase in SRL of 162 ± 36% (mean ± SE; p < 0.05) over baseline and decreased PD400 from a baseline value of 32.5 ± 5.0 to 16.6 ± 1.7 BU (p < 0.05). Pretreatment with the H2O2 scavenger, catalase (CAT,; 38 mg aerosol), methylprednisolone succinate (MS; 1 mg/kg given intravenously), the cyclooxygenase inhibitor, indomethacin (IND; 2 mg/kg given intravenously), and the PAF antagonist, WEB-2086 (3 mg/kg given intravenously) all attenuated the x-xo-induced increase in SRL (p < 0.05); the leukotriene D4 antagonist, MK-571 (5 mg by aerosol) had no effect. All agents inhibited the x-xo-induced decrease in PD400: mean BUs were 27 after CAT, 32 after WEB-2086, 34 after IND, 31 after MS, and 25 after MK-571 (all p < 0.05 versus x-xo alone). In a cell-free system in vitro, x-xo produced 774 ± 41 ng OH·/ml (n = 9) and CAT (50 μg/ml) inhibited this reaction by 74 ± 11% (n = 7, p < 0.05); all other drugs were ineffective, indicating that they did not have nonspecific radical scavenging action. In subsequent experiments, CAT pretreatment had no effect on PAF-induced bronchoconstriction or AHR, suggesting that radical-induced generation of lipid mediators occurred first. These results suggest that in sheep, the secondary generation of arachidonic acid metabolites contributes to x-xo-induced bronchoconstriction and AHR.

UR - http://www.scopus.com/inward/record.url?scp=0026335863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026335863&partnerID=8YFLogxK

M3 - Article

VL - 144

SP - 1291

EP - 1296

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6

ER -